Skip to main content
Heranba Industries Limited logo

Heranba Industries Limited — Investor Relations & Filings

Ticker · HERANBA ISIN · INE694N01015 LEI · 335800OPXIEPYCNRWS37 BSE.NS Manufacturing
Open in API
Filings indexed 443 across all filing types
Latest filing 2023-04-03 Major Shareholding Noti…
Country IN India
Listing BSE.NS HERANBA

About Heranba Industries Limited

https://www.heranba.co.in/

Heranba Industries Limited specializes in the manufacturing and marketing of synthetic pyrethroids and their intermediates. The company operates an integrated business model spanning the production of technicals, formulations, and branded products. Its extensive portfolio includes key active ingredients such as Cypermethrin, Deltamethrin, Alpha Cypermethrin, and Permethrin, catering to agriculture, public health, and animal health sectors. With multiple manufacturing facilities and dedicated R&D capabilities, the company provides a wide range of insecticides, herbicides, and fungicides. Heranba maintains a global footprint, supplying products to over sixty countries while ensuring quality control from intermediate stages to final crop protection solutions.

Recent filings

Filing Released Lang Actions
Acquisition
Major Shareholding Notification Classification · 100% confidence The document is a disclosure under Regulation 29 of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. It details the acquisition of shares by an individual (Raghuram K Shetty) in Heranba Industries Limited, including the number of shares acquired, percentage of shareholding before and after acquisition, mode of acquisition, and dates. This type of filing is a notification of a major shareholding change, specifically a substantial acquisition of shares. It is not a financial report, earnings release, or management discussion. The document fits the definition of a Major Shareholding Notification (MRQ).
2023-04-03 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the closure of the trading window for insiders in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. It informs about the trading restrictions ahead of the announcement of audited financial results for the quarter and year ended March 31, 2023. The document does not contain any financial data, results, or detailed report but is an announcement related to compliance and insider trading restrictions. It is not a financial report, earnings release, or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which covers compliance documents and miscellaneous regulatory announcements.
2023-03-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding scheduled interactions with investors and analysts. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events or information. The content is about informing the exchanges of upcoming meetings and explicitly states no unpublished price sensitive information will be shared. There are no financial statements, detailed financial data, or report attachments. The document length is only 1487 characters, indicating it is a brief announcement rather than a full report. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2023-03-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing stock exchanges about scheduled interactions with investors and analysts. It explicitly states that no unpublished price sensitive information will be shared and is essentially an announcement of investor meetings. The document is short (1548 characters) and does not contain any financial data, results, or detailed reports. It is an update on investor relations activities rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-03-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding scheduled interactions with investors and analysts. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events or information. The content is about announcing upcoming investor meetings and does not contain financial data, audit information, or detailed reports. The document length is only 1492 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2023-03-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing stock exchanges about scheduled interactions with investors and analysts. It explicitly states that no unpublished price sensitive information will be shared and is essentially an announcement of investor meetings. The document length is short (1853 characters) and does not contain any financial data, results, or detailed reports. It is not a financial report, earnings release, or management discussion. It is an update related to investor relations activities, specifically about upcoming meetings. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-02-20 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.